Successful use of nifekalant hydrochloride for 37 days in a patient with refractory ventricular tachycardia following septic shock

Authors :: Takafumi Azami
Akinori Takeuchi
Hiroaki Ito
Kazuya Sobue
Hirotada Katsuya
Shoji Ito
Hiroshi Sasano
Hiroyuki Hirate
Source :: Journal of the Japanese Society of Intensive Care Medicine. 14:345-346
Publication Year :: 2007
Publisher :: Japanese Society of Intensive Care Medicine, 2007.

Subjects :: medicine.medical_specialty
Refractory
Septic shock
business.industry
Internal medicine
Nifekalant hydrochloride
medicine
Cardiology
Ventricular tachycardia
medicine.disease
business

Full Text Access

Tools